Induced Pluripotent Stem Cell Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global induced pluripotent stem cell market looks promising with opportunities in the academic research, drug development & toxicity testing, and regenerative medicine applications. The global induced pluripotent stem cell market is expected to grow with a CAGR of 8%-10% from 2020 to 2025. The major drivers for this market are surge in demand for personalized regenerative cell therapies, increasing prevalence of chronic diseases, and rising usage of genome engineering in personalized medicines.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global induced pluripotent stem cell market report, please download the report brochure.
In this market, research laboratories is the largest end user of induced pluripotent stem cell. Growth in various segments of the induced pluripotent stem cell market are given below:
The study includes trends and forecast for the global induced pluripotent stem cell market by product form, ingredient, species, and region as follows:
By Product Function [Value ($ Million) shipment analysis for 2014 – 2025]:
Within this market, research laboratories will remain the largest end user segment over the forecast period due to increasing cell-based research & clinical trials.
North America will remain the largest region over the forecast period due to rising number of clinical trials & research and increasing adoption of functional cells for pre-clinical screening of drugs in the region.
Features of the Global Induced Pluripotent Stem Cell Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global induced pluripotent stem cell market by product function (molecular & cellular engineering, cellular reprogramming, cell culture, and cell differentiation & cell analysis), derived cell-type (hepatocytes, fibroblasts, keratinocytes, amniotic cells, neuronal cells, cardiac cells, vascular cells, immune cells, renal cells, liver cells, and others), application (academic research, drug development & toxicity testing, and regenerative medicine), end user (research laboratories, biotechnology companies, and hospitals) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global induced pluripotent stem cell market?
Q.5 What are the business risks and threats to the global induced pluripotent stem cell market?
Q.6 What are the emerging trends in this induced pluripotent stem cell market and the reasons behind them?
Q.7 What are some changing demands of customers in this induced pluripotent stem cell market?
Q.8 What are the new developments in this induced pluripotent stem cell market? Which companies are leading these developments?
Q.9 Who are the major players in this induced pluripotent stem cell market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this induced pluripotent stem cell market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global induced pluripotent stem cell market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product Function (Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis), Derived Cell-type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others), Application (Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine), and End User (Research Laboratories, Biotechnology Companies, and Hospitals)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global induced pluripotent stem cell market looks promising with opportunities in the academic research, drug development & toxicity testing, and regenerative medicine applications. The global induced pluripotent stem cell market is expected to grow with a CAGR of 8%-10% from 2020 to 2025. The major drivers for this market are surge in demand for personalized regenerative cell therapies, increasing prevalence of chronic diseases, and rising usage of genome engineering in personalized medicines.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global induced pluripotent stem cell market report, please download the report brochure.
In this market, research laboratories is the largest end user of induced pluripotent stem cell. Growth in various segments of the induced pluripotent stem cell market are given below:
The study includes trends and forecast for the global induced pluripotent stem cell market by product form, ingredient, species, and region as follows:
By Product Function [Value ($ Million) shipment analysis for 2014 – 2025]:
- Molecular & Cellular Engineering
- Cellular Reprogramming
- Cell Culture
- Cell Differentiation & Cell Analysis
- Hepatocytes
- Fibroblasts
- Keratinocytes
- Amniotic Cells
- Neuronal Cells
- Cardiac Cells
- Vascular Cells
- Immune Cells
- Renal Cells
- Liver Cells
- Others
- Academic Research
- Drug Development & Toxicity Testing
- Regenerative Medicine
- Research Laboratories
- Biotechnology Companies
- Hospitals
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Within this market, research laboratories will remain the largest end user segment over the forecast period due to increasing cell-based research & clinical trials.
North America will remain the largest region over the forecast period due to rising number of clinical trials & research and increasing adoption of functional cells for pre-clinical screening of drugs in the region.
Features of the Global Induced Pluripotent Stem Cell Market
- Market Size Estimates: Global induced pluripotent stem cell market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global induced pluripotent stem cell market size by various segments, such as product function, derived cell type, application, and end user in terms of value.
- Regional Analysis: Global induced pluripotent stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product function, derived cell type, application, end user, and region for the global induced pluripotent stem cell market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global induced pluripotent stem cell market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global induced pluripotent stem cell market by product function (molecular & cellular engineering, cellular reprogramming, cell culture, and cell differentiation & cell analysis), derived cell-type (hepatocytes, fibroblasts, keratinocytes, amniotic cells, neuronal cells, cardiac cells, vascular cells, immune cells, renal cells, liver cells, and others), application (academic research, drug development & toxicity testing, and regenerative medicine), end user (research laboratories, biotechnology companies, and hospitals) and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global induced pluripotent stem cell market?
Q.5 What are the business risks and threats to the global induced pluripotent stem cell market?
Q.6 What are the emerging trends in this induced pluripotent stem cell market and the reasons behind them?
Q.7 What are some changing demands of customers in this induced pluripotent stem cell market?
Q.8 What are the new developments in this induced pluripotent stem cell market? Which companies are leading these developments?
Q.9 Who are the major players in this induced pluripotent stem cell market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this induced pluripotent stem cell market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global induced pluripotent stem cell market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product Function (Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis), Derived Cell-type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others), Application (Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine), and End User (Research Laboratories, Biotechnology Companies, and Hospitals)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Induced Pluripotent Stem Cell Market Trends and Forecast
3.3: Global Induced Pluripotent Stem Cell Market by Product Function
3.3.1: Molecular & Cellular Engineering
3.3.2: Cellular Reprogramming
3.3.3: Cell Culture
3.3.4: Cell Differentiation & Cell Analysis
3.4: Global Induced Pluripotent Stem Cell Market by Derived Cell-type
3.4.1: Hepatocytes
3.4.2: Fibroblasts
3.4.3: Keratinocytes
3.4.4: Amniotic Cells
3.4.5: Neuronal Cells
3.4.6: Cardiac Cells
3.4.7: Vascular Cells
3.4.8: Immune Cells
3.4.9: Renal Cells
3.4.10: Liver Cells
3.4.11: Others
3.5: Global Induced Pluripotent Stem Cell Market by Application
3.5.1: Academic Research
3.5.2: Drug Development & Toxicity Testing
3.5.3: Regenerative Medicine
3.6: Global Induced Pluripotent Stem Cell Market by End User
3.6.1: Research Laboratories
3.6.2: Biotechnology Companies
3.6.3: Hospitals
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Induced Pluripotent Stem Cell Market by Region
4.2: North American Induced Pluripotent Stem Cell Market
4.2.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.2.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.2.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.2.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.2.5: The United States Induced Pluripotent Stem Cell Market
4.2.6: The Canadian Induced Pluripotent Stem Cell Market
4.2.7: The Mexican Induced Pluripotent Stem Cell Market
4.3: European Induced Pluripotent Stem Cell Market
4.3.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.3.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.3.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.3.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.3.5: The Induced Pluripotent Stem Cell Market of United Kingdom
4.3.6: The German Induced Pluripotent Stem Cell Market
4.3.7: The French Induced Pluripotent Stem Cell Market
4.4: APAC Induced Pluripotent Stem Cell Market
4.4.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.4.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.4.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.4.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.4.5: The Chinese Induced Pluripotent Stem Cell Market
4.4.6: The Indian Induced Pluripotent Stem Cell Market
4.4.7: The Japanese Induced Pluripotent Stem Cell Market
4.5: ROW Induced Pluripotent Stem Cell Market
4.5.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.5.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.5.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.5.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.5.5: Brazilian Induced Pluripotent Stem Cell Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Product Function
7.1.2: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Derived Cell-type
7.1.3: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Application
7.1.4: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by End User
7.1.5: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Region
7.2: Emerging Trends in the Global Induced Pluripotent Stem Cell Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Induced Pluripotent Stem Cell Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Induced Pluripotent Stem Cell Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Applied StemCell Inc.
8.2: BlueRock Therapeutics
8.3: Corning Life Sciences
8.4: Merck Millipore
8.5: Lonza Group Ltd.
8.6: Promega Corporation
8.7: Therm Fisher Scientific Inc.
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Induced Pluripotent Stem Cell Market Trends and Forecast
3.3: Global Induced Pluripotent Stem Cell Market by Product Function
3.3.1: Molecular & Cellular Engineering
3.3.2: Cellular Reprogramming
3.3.3: Cell Culture
3.3.4: Cell Differentiation & Cell Analysis
3.4: Global Induced Pluripotent Stem Cell Market by Derived Cell-type
3.4.1: Hepatocytes
3.4.2: Fibroblasts
3.4.3: Keratinocytes
3.4.4: Amniotic Cells
3.4.5: Neuronal Cells
3.4.6: Cardiac Cells
3.4.7: Vascular Cells
3.4.8: Immune Cells
3.4.9: Renal Cells
3.4.10: Liver Cells
3.4.11: Others
3.5: Global Induced Pluripotent Stem Cell Market by Application
3.5.1: Academic Research
3.5.2: Drug Development & Toxicity Testing
3.5.3: Regenerative Medicine
3.6: Global Induced Pluripotent Stem Cell Market by End User
3.6.1: Research Laboratories
3.6.2: Biotechnology Companies
3.6.3: Hospitals
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Induced Pluripotent Stem Cell Market by Region
4.2: North American Induced Pluripotent Stem Cell Market
4.2.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.2.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.2.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.2.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.2.5: The United States Induced Pluripotent Stem Cell Market
4.2.6: The Canadian Induced Pluripotent Stem Cell Market
4.2.7: The Mexican Induced Pluripotent Stem Cell Market
4.3: European Induced Pluripotent Stem Cell Market
4.3.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.3.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.3.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.3.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.3.5: The Induced Pluripotent Stem Cell Market of United Kingdom
4.3.6: The German Induced Pluripotent Stem Cell Market
4.3.7: The French Induced Pluripotent Stem Cell Market
4.4: APAC Induced Pluripotent Stem Cell Market
4.4.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.4.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.4.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.4.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.4.5: The Chinese Induced Pluripotent Stem Cell Market
4.4.6: The Indian Induced Pluripotent Stem Cell Market
4.4.7: The Japanese Induced Pluripotent Stem Cell Market
4.5: ROW Induced Pluripotent Stem Cell Market
4.5.1: Market by Product Function: Molecular & Cellular Engineering, Cellular Reprogramming, Cell Culture, and Cell Differentiation & Cell Analysis
4.5.2: Market by Derived Cell-type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neuronal Cells, Cardiac Cells, Vascular Cells, Immune Cells, Renal Cells, Liver Cells, and Others
4.5.3: Market by Application: Academic Research, Drug Development & Toxicity Testing, and Regenerative Medicine
4.5.4: Market by End User: Research Laboratories, Biotechnology Companies, and Hospitals
4.5.5: Brazilian Induced Pluripotent Stem Cell Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Product Function
7.1.2: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Derived Cell-type
7.1.3: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Application
7.1.4: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by End User
7.1.5: Growth Opportunities for the Global Induced Pluripotent Stem Cell Market by Region
7.2: Emerging Trends in the Global Induced Pluripotent Stem Cell Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Induced Pluripotent Stem Cell Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Induced Pluripotent Stem Cell Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Applied StemCell Inc.
8.2: BlueRock Therapeutics
8.3: Corning Life Sciences
8.4: Merck Millipore
8.5: Lonza Group Ltd.
8.6: Promega Corporation
8.7: Therm Fisher Scientific Inc.
8.8: Company
8.9: Company
8.10: Company
